| Figure 1‑1: Orthopedic Biomaterials Device Market Share Ranking by Segment, Global, 2022 |
| Figure 1‑2: Companies Researched in This Report |
| Figure 1‑3: Factors Impacting the Orthopedic Biomaterials Device Market by Segment, Global |
| Figure 1‑4: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2019 – 2022 |
| Figure 1‑5: Orthopedic Biomaterial Procedures Covered |
| Figure 1‑6: Orthopedic Biomaterial Regions Covered, Global (1 of 2) |
| Figure 1‑7: Version History |
| Figure 2‑1: Orthopedic Biomaterials Device Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 2‑2: Orthopedic Biomaterials Device Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 2‑3: Orthopedic Biomaterials Device Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) |
| Figure 3‑1: Bone Graft Substitute Products by Company (1 of 4) |
| Figure 3‑2: Bone Graft Substitute Products by Company (2 of 4) |
| Figure 3‑3: Bone Graft Substitute Products by Company (3 of 4) |
| Figure 3‑4: Bone Graft Substitute Products by Company (4 of 4) |
| Figure 3‑5: Growth Factor Products by Company |
| Figure 3‑6: Cell Therapy Products by Company |
| Figure 3‑7: Hyaluronic Acid Viscosupplementation by Products by Company |
| Figure 3‑8: Cartilage Repair Products by Company |
| Figure 3‑9: Class 2 Device Recall Bioactive Bone Graft Putty |
| Figure 3‑10: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty |
| Figure 3‑11: Class 2 Device Recall Opteform Allograft Disc |
| Figure 3‑12: Class 2 Device Recall INFUSE Bone Graft X SMALL KIT |
| Figure 3‑13: Class 2 Device Recall SynviscOne |
| Figure 3‑14: Class 2 Device Recall PROSTIM 10cc INJECTABLE |
| Figure 3‑15: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty |
| Figure 3‑16: Class 1 Device Recall EBI Osteogen Implantable Bone Growth Stimulator |
| Figure 3‑17: NOVOCART 3D Treatment Following Microfracture Failure |
| Figure 3‑18: NOVOCART®3D for Treatment of Articular Cartilage of the Knee (N3D) |
| Figure 3‑19: Demineralized Bone Matrix Rotator Cuff Study |
| Figure 3‑20: ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery |
| Figure 3‑21: A Post Market Surveillance on INFUSE Bone Graft |
| Figure 3‑22: Prospective SPINE Registry (SPINE) |
| Figure 3‑23: ACDF Using Structural Allograft vs. Tritanium C |
| Figure 3‑24: Non-interventional Study in Pediatric Patients Treated With NOVOCART Inject in the Knee (NINJA) |
| Figure 3‑25: Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients (JUNOVO) |
| Figure 3‑26: NOVOCART® Inject Plus for Cartilage Defects of the Knee |
| Figure 3‑27: Phase III Study to Evaluate Safety and Effectiveness of NOVOCART 3D Plus vs. Microfracture in Knee Cartilage Defects (N3D) |
| Figure 3‑28: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee (PEAK) |
| Figure 3‑29: Clinical Study to Evaluate Adaptos®Ortho Wedge Bone Graft Substitute in High Tibial Osteotomy: A Randomized, Controlled, Partially Blinded, Multi-Center Trial |
| Figure 3‑30: Novel Porous Bioceramic Material as a Bone Substitute |
| Figure 3‑31: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE) |
| Figure 3‑32: Multicentric Observational Study on the Use of a Human Bone Graft in Osteochondral Defects |
| Figure 3‑33: Long-term Safety and Effectiveness of AUGMENT® Injectable Bone Graft Compared to Autologous Bone Graft |
| Figure 3‑34: A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle |
| Figure 3‑35: Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects |
| Figure 3‑36: Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear |
| Figure 3‑37: PRP Versus HA in Osteoarthritis of the Patellofemoral Joint |
| Figure 3‑38: The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome (PRP) |
| Figure 3‑39: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine |
| Figure 3‑40: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain |
| Figure 3‑41: A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis |
| Figure 3‑42: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC) |
| Figure 3‑43: Bone Marrow Aspirate Concentrate Use in Hip Osteoarthritis (BMAC) |
| Figure 3‑44: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis. |
| Figure 3‑45: Clinical Registry Assessment of the Missouri Osteochondral Allograft Preservation System - MOPS |
| Figure 3‑46: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella |
| Figure 3‑47: Autologous Bone Marrow Concentrate in Knee Osteochondral Allograft Transplantation |
| Figure 3‑48: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis |
| Figure 3‑49: A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects |
| Figure 3‑50: Phase 2 Clinical Trial of CartiLife® in the United States |
| Figure 4‑1: Orthopedic Biomaterials Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 4‑2: Orthopedic Biomaterials Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 4‑3: Leading Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2022 |
| Figure 4‑4: SWOT Analysis, Arthrex |
| Figure 4‑5: SWOT Analysis, Bioventus |
| Figure 4‑6: SWOT Analysis, DePuy Synthes |
| Figure 4‑7: SWOT Analysis, Ferring Pharmaceuticals |
| Figure 4‑8: SWOT Analysis, Fidia Farmaceutici |
| Figure 4‑9: SWOT Analysis, Harvest Technologies |
| Figure 4‑10: SWOT Analysis, Medtronic |
| Figure 4‑11: SWOT Analysis, MTF |
| Figure 4‑12: SWOT Analysis, Surgalign Holdings |
| Figure 4‑13: SWOT Analysis, Sanofi |
| Figure 4‑14: SWOT Analysis, Sanofi |
| Figure 4‑15: SWOT Analysis, Stryker |
| Figure 4‑16: SWOT Analysis, Vericel Corporation |
| Figure 4‑17: SWOT Analysis, Zimmer Biomet |
| Figure 5‑1: Orthopedic Bone Graft Substitute Regions Covered, Global (1 of 2) |
| Figure 5‑2: Orthopedic Bone Grafting Procedures by Segment, Global, 2019 – 2029 |
| Figure 5‑3: Orthopedic Bone Grafting Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑4: Orthopedic Bone Grafting Procedures by Country, North America, 2019 – 2029 |
| Figure 5‑5: Orthopedic Bone Grafting Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 5‑6: Orthopedic Bone Grafting Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 5‑7: Orthopedic Bone Grafting Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 5‑8: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 5‑9: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 5‑10: Orthopedic Bone Grafting Procedures by Country, Middle East, 2019 – 2029 |
| Figure 5‑11: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 5‑12: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 5‑13: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 5‑14: Orthopedic Bone Grafting Procedures by Country, Africa, 2019 – 2029 |
| Figure 5‑15: Allograft Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑16: Allograft Procedures by Country, North America, 2019 – 2029 |
| Figure 5‑17: Allograft Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 5‑18: Allograft Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 5‑19: Allograft Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 5‑20: Allograft Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 5‑21: Allograft Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 5‑22: Allograft Procedures by Country, Middle East, 2019 – 2029 |
| Figure 5‑23: Allograft Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 5‑24: Allograft Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 5‑25: Allograft Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 5‑26: Allograft Procedures by Country, Africa, 2019 – 2029 |
| Figure 5‑27: Demineralized Bone Matrix Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑28: Demineralized Bone Matrix Procedures by Country, North America, 2019 – 2029 |
| Figure 5‑29: Demineralized Bone Matrix Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 5‑30: Demineralized Bone Matrix Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 5‑31: Demineralized Bone Matrix Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 5‑32: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 5‑33: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 5‑34: Demineralized Bone Matrix Procedures by Country, Middle East, 2019 – 2029 |
| Figure 5‑35: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 5‑36: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 5‑37: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 5‑38: Demineralized Bone Matrix Procedures by Country, Africa, 2019 – 2029 |
| Figure 5‑39: Synthetic Procedures by Region, Global, 2019 – 2029 |
| Figure 5‑40: Synthetic Procedures by Country, North America, 2019 – 2029 |
| Figure 5‑41: Synthetic Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 5‑42: Synthetic Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 5‑43: Synthetic Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 5‑44: Synthetic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 5‑45: Synthetic Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 5‑46: Synthetic Procedures by Country, Middle East, 2019 – 2029 |
| Figure 5‑47: Synthetic Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 5‑48: Synthetic Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 5‑49: Synthetic Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 5‑50: Synthetic Procedures by Country, Africa, 2019 – 2029 |
| Figure 5‑51: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 5‑52: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 5‑53: Orthopedic Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑54: Units Sold by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑55: Average Selling Price by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 – 2029 (US$) |
| Figure 5‑56: Market Value by Region, Orthopedic Bone Graft Substitute Market, Global, 2019 – 2029 (US$M) |
| Figure 5‑57: Allograft Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑58: Units Sold by Region, Allograft Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑59: Average Selling Price by Region, Allograft Bone Graft Substitute Market, Global, 2019 – 2029 (US$) |
| Figure 5‑60: Market Value by Region, Allograft Bone Graft Substitute Market, Global, 2019 – 2029 (US$M) |
| Figure 5‑61: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑62: Units Sold by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑63: Average Selling Price by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 – 2029 (US$) |
| Figure 5‑64: Market Value by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2019 – 2029 (US$M) |
| Figure 5‑65: Synthetic Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑66: Units Sold by Region, Synthetic Bone Graft Substitute Market, Global, 2019 – 2029 |
| Figure 5‑67: Average Selling Price by Region, Synthetic Bone Graft Substitute Market, Global, 2019 – 2029 (US$) |
| Figure 5‑68: Market Value by Region, Synthetic Bone Graft Substitute Market, Global, 2019 – 2029 (US$M) |
| Figure 5‑69: Allograft Bone Graft Substitute Units Sold by Indication, Global, 2019 – 2029 |
| Figure 5‑70: Spine Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑71: Trauma Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑72: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑73: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, Global, 2019 – 2029 |
| Figure 5‑74: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑75: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑76: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑77: Synthetic Bone Graft Substitute Units Sold by Indication, Global, 2019 – 2029 |
| Figure 5‑78: Spine Synthetic Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑79: Trauma Synthetic Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑80: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, Global, 2019 – 2029 |
| Figure 5‑81: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2022 |
| Figure 6‑1: Orthopedic Growth Factor Procedures by Region, Global, 2019 – 2029 |
| Figure 6‑2: Orthopedic Growth Factor Procedures by Country, North America, 2019 – 2029 |
| Figure 6‑3: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 6‑4: Orthopedic Growth Factor Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 6‑5: Orthopedic Growth Factor Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 6‑6: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 6‑7: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 6‑8: Orthopedic Growth Factor Procedures by Country, Middle East, 2019 – 2029 |
| Figure 6‑9: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 6‑10: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 6‑11: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 6‑12: Orthopedic Growth Factor Procedures by Country, Africa, 2019 – 2029 |
| Figure 6‑13: Orthopedic Growth Factor Market, Global, 2019 – 2029 |
| Figure 6‑14: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2019 – 2029 |
| Figure 6‑15: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2019 – 2029 (US$) |
| Figure 6‑16: Market Value by Region, Orthopedic Growth Factor Market, Global, 2019 – 2029 (US$M) |
| Figure 6‑17: Leading Competitors, Orthopedic Growth Factor Market, Global, 2022 |
| Figure 7‑1: Orthopedic Cell Therapy Procedures by Segment, Global, 2019 – 2029 |
| Figure 7‑2: Orthopedic Cell Therapy Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑3: Orthopedic Cell Therapy Procedures by Country, North America, 2019 – 2029 |
| Figure 7‑4: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 7‑5: Orthopedic Cell Therapy Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 7‑6: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 7‑7: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 7‑8: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 7‑9: Orthopedic Cell Therapy Procedures by Country, Middle East, 2019 – 2029 |
| Figure 7‑10: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 7‑11: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 7‑12: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 7‑13: Orthopedic Cell Therapy Procedures by Country, Africa, 2019 – 2029 |
| Figure 7‑14: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑15: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2019 – 2029 |
| Figure 7‑16: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 7‑17: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 7‑18: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 7‑19: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 7‑20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 7‑21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2019 – 2029 |
| Figure 7‑22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 7‑23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 7‑24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 7‑25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2019 – 2029 |
| Figure 7‑26: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2019 – 2029 |
| Figure 7‑27: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2019 – 2029 |
| Figure 7‑28: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 7‑29: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 7‑30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 7‑31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 7‑32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 7‑33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2019 – 2029 |
| Figure 7‑34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 7‑35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 7‑36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 7‑37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2019 – 2029 |
| Figure 7‑38: Orthopedic Cell Therapy Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 7‑39: Orthopedic Cell Therapy Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 7‑40: Platelet-Rich Plasma Market, Global, 2019 – 2029 |
| Figure 7‑41: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029 |
| Figure 7‑42: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029 (US$) |
| Figure 7‑43: Market Value by Region, Platelet-Rich Plasma Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑44: Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 |
| Figure 7‑45: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 |
| Figure 7‑46: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 (US$) |
| Figure 7‑47: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2019 – 2029 (US$M) |
| Figure 7‑48: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2022 |
| Figure 8‑1: Hyaluronic Acid Viscosupplementation Regions Covered, Global (1 of 2) |
| Figure 8‑2: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2019 – 2029 |
| Figure 8‑3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, North America, 2019 – 2029 |
| Figure 8‑4: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 8‑5: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 8‑6: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 8‑7: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 8‑8: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 8‑9: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 8‑10: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 8‑11: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 8‑12: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 8‑13: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Africa, 2019 – 2029 |
| Figure 8‑14: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 8‑15: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 8‑16: Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑17: Units Sold by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑18: Average Selling Price by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$) |
| Figure 8‑19: Market Value by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑20: Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑21: Units Sold by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑22: Average Selling Price by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$) |
| Figure 8‑23: Market Value by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑24: Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑25: Units Sold by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑26: Average Selling Price by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$) |
| Figure 8‑27: Market Value by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑28: Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑29: Units Sold by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑30: Average Selling Price by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$) |
| Figure 8‑31: Market Value by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑32: Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑33: Units Sold by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 |
| Figure 8‑34: Average Selling Price by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$) |
| Figure 8‑35: Market Value by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2019 – 2029 (US$M) |
| Figure 8‑36: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2022 |
| Figure 9‑1: Orthopedic Cartilage Repair Regions Covered, Global (1 of 2) |
| Figure 9‑2: Orthopedic Cartilage Repair Regions Covered, Global (2 of 2) |
| Figure 9‑3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2019 – 2029 |
| Figure 9‑4: Orthopedic Cartilage Repair Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑5: Osteochondral Allograft Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑6: Meniscal Allograft Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑7: Autologous Chondrocyte Implantation Procedures by Region, Global, 2019 – 2029 |
| Figure 9‑8: Orthopedic Cartilage Repair Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 9‑9: Orthopedic Cartilage Repair Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 9‑10: Orthopedic Cartilage Repair Market, Global, 2019 – 2029 |
| Figure 9‑11: Units Sold by Region, Orthopedic Cartilage Repair Market, Global, 2019 – 2029 |
| Figure 9‑12: Average Selling Price by Region, Orthopedic Cartilage Repair Market, Global, 2019 – 2029 (US$) |
| Figure 9‑13: Market Value by Region, Orthopedic Cartilage Repair Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑14: Osteochondral Allograft Market, Global, 2019 – 2029 |
| Figure 9‑15: Units Sold by Region, Osteochondral Allograft Market, Global, 2019 – 2029 |
| Figure 9‑16: Average Selling Price by Region, Osteochondral Allograft Market, Global, 2019 – 2029 (US$) |
| Figure 9‑17: Market Value by Region, Osteochondral Allograft Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑18: Meniscal Allograft Market, Global, 2019 – 2029 |
| Figure 9‑19: Units Sold by Region, Meniscal Allograft Market, Global, 2019 – 2029 |
| Figure 9‑20: Average Selling Price by Region, Meniscal Allograft Market, Global, 2019 – 2029 (US$) |
| Figure 9‑21: Market Value by Region, Meniscal Allograft Market, Global, 2019 – 2029 (US$M) |
| Figure 9‑22: Autologous Chondrocyte Implantation Market, Global, 2019 – 2029 |
| Figure 9‑23: Units Sold by Region, Autologous Chondrocyte Implantation Market, Global, 2019 – 2029 |
| Figure 9‑24: Average Selling Price by Region, Autologous Chondrocyte Implantation Market, Global, 2019 – 2029 (US$) |
| Figure 9‑25: Market Value by Region, Autologous Chondrocyte Implantation Market, Global, 2019 – 2029 (US$M) |
Medtronic has maintained a strong presence in the total orthopedic biomaterials device market through brand recognition, strong customer support and a large sales force. The company held the largest share of the orthopedic bone graft substitute segment and dominated in the orthopedic growth factor market due to the success of its INFUSE™ product.
